Latest articles: Potential pitfall: Metastatic spinal cord compression (MSCC) is a medical emergency which can result in paralysis. Many patients living with cancer have pain; within primary care it can difficult to differentiate between significant pain which may be...
Latest articles: Thursday 21st May 2020 Managing a patient’s fear of cancer recurrence and health anxiety can be difficult. After treatment, many patients want to have the reassurance that they are cured. Generally it is not possible for health care professionals to...
Cancer Keys: PPIs masking red flag symptoms for stomach cancer
Proton Pump Inhibitors (PPIs) are widely used to treat acid reflux and dyspepsia. NICE cautions that PPIs can mask or alter symptoms of stomach cancer, leading to later diagnoses.
Patients on PPIs who have developed stomach cancer may increase their doses to manage further acid reflux and dyspepsia, further masking red flag symptoms. However, symptoms may become resistant or alter in character – perhaps manifesting as pain rather than burning, for instance.
NICE NG12 guidelines advise to consider non‑urgent direct access upper gastrointestinal endoscopy to assess for stomach cancer in people aged 55 or over with treatment‑resistant dyspepsia.
Offer urgent direct access upper gastrointestinal endoscopy (to be performed within 2 weeks) to assess for stomach cancer in people with dysphagia, or aged 55 and over with weight loss and any of the following: upper abdominal pain, reflux, dyspepsia.
Cancer Keys are brought to you by GatewayC.
Download this Cancer Key here
Access GatewayC’s course on early diagnosis of stomach cancer here.